Search Results

You searched for : Sanofi  

AI for Rare Diseases: Can Algorithms Help Doctors Solve Diagnostic Mysteries?

AI algorithms are reshaping rare disease diagnosis in India by analysing genomics, imaging, and health records, offering hope to millions facing prolonged diagnostic delays. ...
Sep 09

BioAsia 2026 an Unprecedented Success - Cementing Telangana’s Global Leadership in TechBio and Life Sciences

...
Feb 18

BioAsia 2026 focuses on the Global TechBio for the Future of Life Sciences

23rd edition of Asia’s flagship life sciences forum on AI, automation and next wave of healthcare innovation opens in the city. ...
Feb 17

BioAsia 2026 to Convene the World’s Leading Science, AI, and Industry Pioneers Driving the TechBio Revolution

Global innovators shaping AI-native biology, next-generation medicines and digital-first healthcare to chart the future of global health....
Feb 05

Sanofi India Limited appoints new Managing Director

Sanofi India Limited (SIL) today announced that its Board of Directors, on the recommendation of the Nomination and Remuneration Committee, has appointed Deepak Arora as ...
Oct 27

Sanofi’s diabetes drug Soliqua® now available in India

A simple to initiate once-daily solution that breaks through the complexity of living with type 2 diabetes. Nominal therapy cost enables wider access to ...
Apr 30

Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in India

While Sanofi India will continue to own, import, and manufacture its complete range of CNS products across plants in India and internationally, Cipla will leverage ...
Mar 26

1 Press Note Sanofi India Limited and Emcure Pharmaceuticals announce exclusive distribution partnership to broaden reach of Sanofi’s Cardiovascular brands

Sanofi continues to give fresh impetus to its business in the Country with an accelerated growth plan - ‘India for India’, across its pharmaceuticals, specialty, consumer ...
Mar 13

Sanofi completes acquisition of Kadmon

Latest pharma news updates...
Nov 12

Sanofi completes acquisition of Translate Bio, accelerating the application of mRNA in new vaccines and therapeutics

Latest pharma news update...
Sep 20

Sanofi to acquire Translate Bio; advances deployment of mRNA technology across vaccines and therapeutics

Corporate Pharma news upedat...
Aug 05

Dupixent significantly improved itch and hives in patients with chronic spontaneous urticaria

Fifth disease that Dupixent has demonstrated positive pivotal results....
Jul 29

Dupixent significantly improved itch and hives in patients with chronic spontaneous urticaria

Fifth disease that Dupixent has demonstrated positive pivotal results....
Jul 29

LabGenius announces research collaboration with Ablynx, a Sanofi Company

Latest pharma update : Research and Collaboration...
Jul 17

Sanofi extends collaboration with Genedata for Pharmaceutical Development & Manufacturing Science

Latest FDA approvals update...
Jul 16

Sanofi streamlines Consumer Healthcare portfolio in Latin America with divestiture of eight brands to Hypera Pharma

As discussed during our Capital Markets Day in February, simplifying the CHC product portfolio is an important part of our strategy to focus our resources ...
Jul 14

Sanofi, GSK get approval for Phase 3 COVID-19 vaccine trial in India

In a two-stage approach, the study will initially investigate the efficacy of a vaccine formulation targeting the original virus strain (D.614), while a ...
Jul 09

Sanofi and Translate Bio initiate Phase 1 clinical trial of mRNA influenza vaccine

Trial will evaluate potential of next generation of influenza vaccines with combined mRNA technology and flu vaccine development expertise...
Jun 22

European Commission approves Aubagio (teriflunomide) as the first oral MS therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis

The approval confirms Aubagio as the first oral multiple sclerosis (MS) therapy for first-line treatment of children and adolescents with MS in the European ...
Jun 19

New pivotal data at EHA 2021 reinforces sutimlimab as a first-in-class investigational C1s inhibitor, the first approved treatment for hemolysis

...
Jun 11

Moderna announces agreement with Sanofi for manufacturing of the Moderna COVID-19 Vaccine in the U.S.

Moderna and Sanofi collaborate for covid vaccine manufacturing...
Apr 28

ProBioGen licenses GlymaxX Technology to Sanofi

GlymaxX enables a boost of antibody-dependent cell-mediated cytotoxicity (ADCC)...
Mar 18

Sanofi's mRNA vaccine would not be available this year ; CEO

It could be of use at a later stage all the more if the fight against variants was to continue, said the CEO ...
Feb 15

Sanofi to acquire Kymab, adding KY1005 to its pipeline, a human monoclonal antibody targeting key immune system regulator OX40L

KY1005 binds to OX40-Ligand and has the potential to treat a wide variety of immune-mediated diseases and inflammatory disorders....
Jan 13

Sanofi to acquire Kymab, adding KY1005 to its pipeline

Sanofi and Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibodies with a focus on immune-mediated diseases and immuno-oncology therapeutics...
Jan 11

25 Matching result(s) found!

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026